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ABSTRACT
The primary purpose o f this investigation was to examine the relationship between 
dietary and whole blood ionic magnesium (iMg) and measures o f blood pressure (BP) 
(SBP-systolic BP; DBP-diastolic BP; MAP-mean arterial pressure) in a normotensive 
sample. A secondary purpose was to examine the relationship between dietary and whole 
blood ionic calcium (iCa), sodium (iNa), and potassium (ifC) and measures o f BP. 
Comparisons between BP and PAS (physical activity score) and BMI (body mass index) 
were also made. Subjects (119 females; 82 males) were physically active students with an 
average age of 21.1 years. Participants underwent three BP measurements and whole 
blood samples were collected and analyzed for iMg, iCa, iNa, and LK. Physical activity 
levels were assessed by a physical activity questionnaire (PAQ) and mineral intakes were 
determined by analysis of a three-day dietary record. Examination of each factor with BP 
was performed in a 2X2 fashion using the McNemar chi-square and kappa test statistics. 
Relative Risks (RR) and Odds Ratios (OR) were also determined. No protective influence 
was observed between BP and dietary or ionic measures o f magnesium. Negative 
associations between BP and iNa, dietary Na, and BMI were demonstrated. It was 
concluded that in normotensive subjects, dietary and ionic magnesium does not 
demonstrate a relationship with BP.
Ill
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CHAPTER ONE: INTRODUCTION
1.1 PURPOSE
The primary purpose o f  this investigation was to examine the relationship between 
dietary and whole blood ionic magnesium (iMg) and measures o f blood pressure (BP) 
(SBP-systolic BP; DBP- diastolic BP; MAP-mean arterial pressure) in a normotensive 
sample. A  secondary purpose was to examine the relationship between dietary and whole 
blood ionic calcium (iCa), sodium (iNa), and potassium (iK) and measures of BP. 
Comparisons between BP and PAS (Physical Activity Score on Canadian Physical 
Activity Fimess and Lifestyle Assessment questionnaire) and body mass index (BMI) 
were also made.
1.2 IMPORTANCE OF THE STUDY
Cardiovascular diseases (CVD) such as coronary heart disease (CHD) and stroke are 
the leading cause o f death in all industrialized countries (Kaplan, 1986). Since 
hypertension is the most prevalent risk factor for CVD (Whelton & Klag, 1989), it has 
been recognized by the World Health Organization (WHO) as a major public health 
problem (Yamori et al., 1990). Recommendations of the WHO have placed emphasis on 
a community-wide strategy for the primary prevention o f hypertension and CVD based 
on dietary improvement (Yamori et al., 1990). Whelton and Klag (1989) comment that 
our traditional approach to the prevention of blood pressure (BP) related cardiovascular 
diseases is to detect and treat those at highest risk o f having high blood pressure. They 
further suggest that this strategy is an inadequate response to the current epidemic of 
blood pressure related CVD and should be coupled with a population-based approach that 
seeks to reduce blood pressure in the entire community. The WHO advocates dietary 
improvement as such an approach (Yamori et al., 1990).
Over the years, there has been a belief that a diet high in sodium or low in magnesium 
potassium, or calcium predisposes people to high BP (Burgess et al., 1999). This belief is 
supported by epidemiological, physiologic, and clinical studies that indicate that the 
mineral elements magnesium (Mg), potassium (K), calcium (Ca), and sodium (Na) play a 
central role in vascular smooth muscle contraction and the normal regulation of BP
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(Kaipannen, 1991; Burgess et al., 1999). This is o f particular importance as it is an 
increased vascular resistance that accounts for raised BP in most patients with 
hypertension (Ives, 1989; Karpannen, 1991). These regulatory agents (Mg, K, Ca, Na) 
are usually derived firom various foods and drinks, and are occasionally administered as 
drugs (Karpannen, 1991). Once in the blood, the transport and interaction o f these ions 
(Na+, K+, Ca2+, Mg2+) across the vascular smooth muscle membrane influences the 
intracellular calcium ion concentration and contractile activity o f the cell (Ives, 1989). A  
rise in intracellular Ca2+ increases the formation o f  the calcium-calmodulin complex, 
triggering vascular smooth muscle contraction and increasing blood pressure (Karpannen,
1991). Most hypothesis linking abnormalities in ion transport to hypertension considers 
intracellular Ca2+ as the flnal common mediator o f vascular tone (Ives, 1989).
Among the cationic regulators o f vascular smooth muscle contraction, Mg2+ has a 
major role as it directly competes for Ca2+ binding sites at the cell membrane (Altura, 
Altura, Carella & Turlapaty, 1981a). According to Altura et al. (1981a), the higher the 
extracellular magnesium concentration, the more effective it is at blocking a rise in 
intracellular calcium. This has become the physiologic rationale for the reported 
associations between hypertension and sub-optimal magnesium intakes and ionic blood 
concentrations. (Dyckner and Wester, 1983; Altura, 1984; Seelig, 1994; Whang & 
Whang, 1994; Shirey, 1995; Altura & Altura, 1996;). This may also counteract the 
hypertensive effects o f excess sodium intake (Karpannen, 1991).
Most studies involving mineral intakes and BP have involved the clinical 
supplementation o f Mg, K, or Ca, (Kaplan, 1986; Burgess et al., 1999) and/or dietary 
restriction o f Na (Muntzel & Drueke, 1992) in hypertensive (symptomatic) individuals. 
The results o f epidemiological studies o f the relationship between dietary minerals and 
BP in normotensive (asymptomatic) individuals have been inconsistent (Burgess et al, 
1999). Consistency is important in order to establish dietary recommendations on mineral 
intakes for the prevention o f hypertension. This study similarly examined the relationship 
between dietary mineral intakes and BP in normotensive individuals. Of primary interest 
was the relationship between Mg and BP in view o f the potentially beneficial and 
protective influence suggested by Whelton and Klag (1989), Shirey (1995), and Altura 
and Altura (1996). Additionally, the ionic concentration of Mg2+ and other blood
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cations (Ca2+, Na+, K+) was determined in whole blood, using an ion selective electrode 
(ISE) (Nova Biomedical, Canada: model 11-3C). This allowed for the examination of 
Mg2+, Ca2+, Na+, and K+ in the form in which they exert influence on vascular smooth 
muscle contraction and blood pressure (Shirey, 1995). As dietary estimates may not 
necessarily reflect the cationic blood levels o f  these minerals, the precise determination 
o f  ionic concentrations improved comparisons with BP by providing a direct physiologic 
measure.
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1.3 DEFINITIONS
(1) Ionic Magnesium (iMg): a measure o f that fraction of whole blood magnesium which 
is physiologically active; neither bound to other ions or protein (Elin, 1992).
(a) Normal iMg range (mmol/L): 0.460 - 0.600 mmoI/L (Ising, Bertschat, Gunther, 
Jeremias, & Jeremias, 1995)
(b) D ic te n t iMg range (mmol/L): < 0.450 mmol/L (Ising et al., 1995)
(2) Total Magnesium (tMg): a measure o f whole blood magnesium that includes ionic 
magnesium, complexed magnesium, and protein bound magnesium (Elin, 1992).
(3) Ion Sensitive Electrode (ISE): allows for the precise determination o f ions such as 
magnesium, without interference from other cations, enabling the determination of 
independent blood ionic (iCa, iNa, iMg, iK) profiles (Altura, 1996).
(4) Diastolic Blood Pressure (DBP): Pressure o f blood (mmHg) against the vasculature, 
during the relaxation phase o f the heart (Guyton, PG 165.).
(5) Systolic Blood Pressure (SYS): Pressure o f blood (mmHg) against the vasculature, 
during the contractile phase o f the heart (Guyton, pg.l65).
(6) Mean Arterial Pressure (MAP): The average blood pressure during the cardiac cycle 
determined from DBP and SBP by the equation MAP = DBP + 1/3(SBP-DBP) 
(Guyton, pgl65).
(7) Normotensive BP: A DBP< 90 and a SBP<140 (Tomiak & Gentleman, 1993).
(8) Hypertensive BP: A DBP >95 or a SBP >160 (Tomiak & Gentleman, 1993).
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1.4 ABBREVIATIONS
ATP - Adenosine Triphosphate
BMI - Body Mass Index (kg/m^)
BP - Blood Pressure
Ca - Mineral Calcium (dietary)
Ca2+ - Ionic Calcium (extracellular or intracellular calcium ions)




iCa - Ionic Calcium (referring to the calcium measure in blood)
iK - Ionic Potassium (referring to the potassium measure in blood)
iMg - Ionic Magnesium (referring to the magnesium measure in blood)
iNa - Ionic Sodium (referring to the sodium measure in blood)
ISE - Ion Sensitive Electrode
K - Mineral Potassium (dietary)
K+ - Ionic Potassium (extracellular or intracellular potassium ions)
MAP - Mean Arterial Pressure
Mg - Mineral Magnesium (dietary)
Mg2+ - Ionic Magnesium (extracellular or intracellular magnesium ions)
Mg2+-ATP - Magnesium-Adenosine Triphosphate
Na - Sodium (dietary)
Na+ - Ionic Sodium (extracellular or intracellular sodium ions)
Na+/K+-ATPase - Sodium-Potassium Pump
OR - Odds Ratio
PAS - Physical Activity Score
RR - Relative Risk
SBP - Systolic Blood Pressure
tMg - Total Magnesium
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.5 LIMITATIONS
(1) The dietary analyses depended on the consistency and accuracy of subjects’ self- 
reported journals. Food scores were generated using software and food database by 
NutriQuest (McGraw-Hill, 1998). Scores were estimates based on the average 
micronutrient and macronutrient composition o f common food items. As such, it is 
acknowledged that the assessment o f dietary intakes were inherently limited in their 
degree o f  accuracy. Attempting to improve this accuracy, dietary records were taken for 
three-day periods (2 weekdays and 1 weekend day) and averaged.
(2) The accuracy o f  blood pressure measurements was a source o f  potential error. 
Minimizing this error and improving blood pressure estimates, SBP and DBP 
measurements were taken three times by the same technician and reported as the mode 
score. (If  no modal score resulted, the median score was then taken).
(3) The analysis o f ionic magnesium and other hematological variables was dependent on 
tiie accuracy o f  the ion selective electrode (ISE). The ISE used was the multi-test Stat 
Profile Ultra Analyzer model 1 l-3c (Nova Biomedical Canada Ltd., Mississauga, ON).
1.6 DELIMITATIONS
This study was delimited to 201(82 male; 119 female) Lakehead University 
Kinesiology students. These students were predominantly in their 3rd year of study, 
having an average age o f 21.4 years for males and 20.9 years for females. This was a 
physically active and asymptomatic sample.
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CHAPTER TWO; LITERATURE REVIEW
2.1 INTRODUCTION
This literature review examines the physiologic roles, uptake and metabolism o f 
magnesium with a primary focus on the implications for the regulation o f blood pressure. 
Clinical, epidemiological and experimental evidence regarding magnesium(iMg and 
dietary Mg) and blood pressure (BP) will be presented. Additionally, current theories as 
to the role o f magnesium deficiency in the etiology o f hypertension will be stated. 
Included in this section will be a discussion o f other important and relevant blood ions, 
Ca2+, K+, and Na+. The final section o f  this review will examine dietary and lifestyle 
factors that have been found to correlate to BP.
2.2 MAGNESIUM: AN OVERVIEW OF ITS PHYSIOLOGIC ROLES
According to Altura and Altura (1996), magnesium (Mg2+) is a cofactor for over 300 
enzymes, which play central roles in the control o f neuronal activity, cardiac excitability, 
neuromuscular transmission, muscular contraction, and vasomotor tone. These 
physiologic roles are the consequence o f  biochemical activities in which Mg2+ is 
involved in cellular energy production, protein synthesis, adenylate cyclase synthesis, and 
electrolyte transport. These biochemical fimctions occur intracellularly, with Mg2+-ATP 
acting as an obligate substrate for a wide variety o f enzymes (Altura & Altura, 1996).
The involvement of Mg2+ in the storage and utilization o f energy is through the 
activation of phosphatases and phosphokinases (Altura & Altura, 1984; 1991a). In turn, 
these phosphatases exert control on the intermediates of metabolism through such rate- 
limiting enzymes as hexokinase, pyruvate dehydrogenase, and enolase. In total, Mg2+ is 
involved in the regulation o f 7 enzymes in glycolysis, and 4 enzymes in the citric acid 
cycle. As a consequence, it is integral to the metabolism o f fat, carbohydrate, and protein 
(Altura & Altura, 1984; 1991a).
Mg2+ is also involved in the regulation o f deoxyribonucleic acid(DNA) and 
ribonucleic (RNA) synthesis. Within the cell’s nucleus, Mg2+ is bound to the pentose 
phosphate backbone of DNA, regulating DNA synthesis and cell growth (Altura &
Altura, 1996). Additionally, Mg2+ controls hemoglobin function as most of the ATP in
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red blood cells is bound to the mineral in the Mg2+-ATP complex. There is also evidence 
that the synthesis o f erythrocyte 2,3-diphosphoglycerate (2,3-DPG) is Mg2+ dependent 
through the activation o f hexokinase. Thus, the delivery o f oxygen to working muscles 
may be controlled by Mg2+, implying that the maintenance o f adequate Mg2+ levels is 
important for the efficient delivery o f oxygen (Casoni et al.,1990).
Magnesium also exercises control over electrolyte balance across the cell membrane 
through its obligate substrate association with the sodium-potassium (Na+-K+)-pump 
through Mg2+-ATP. This, in turn, “fuels” the pump so that K+ can be pmnped into the 
cell, and Na+ out o f the cell, establishing the electrical gradient necessary for the 
conduction o f action potentials(Shirey, 1995; Altura & Altura, 1984; 1991a) Similarly, 
the Ca2+-ATPase pump is associated with Mg2+-ATP, and is involved in pumping Ca2+ 
out o f the cell, lowering intracellular levels o f Ca2+, and allowing for muscle relaxation 
(Altura & Altura, 1996). Additionally, Mg2+ competes with Ca2+ for extracellular 
membrane binding sites on the muscle cell (smooth, cardiac, or skeletal), decreasing 
Ca2+ binding, entry into the cell, and release fi-om the sarcoplasmic reticulum(Altura & 
Altura, 1996). In the presence of a decreased extracellular Mg2+ there is a greater uptake 
of Ca2+ into the cell (Shirey, 1995). As calcium initiates muscle contractile processes, 
elevated calcium levels can lead to increased contraction and hypertension, tachycardia, 
neuromuscular irritability and muscle cramps (Shirey, 1995). Conversely, if  one has an 
elevated extracellular Mg2+, intracellular Ca2+ will decrease, resulting in hypotension 
and bradycardia(Shirey, 1995). These processes, however, will be elaborated on in the 
discussion o f magnesium’s role in the etiology of hypertension.
Finally, Mg2+ is an antioxidant, inhibiting the formation o f fi-ee radicals, which 
oxidize essential molecules and cause cellular damage (Rice, 1983). Damage can occur, 
for example, when cholesterol is oxidized, availing it for easier attachment to the arterial 
wall, increasing the risk for heart disease. Mg2+ also acts as a sedative on nerves and 
muscles by decreasing or blocking the release of acetylcholine at nerve endings and has 
also been found to influence temperature regulation, wound healing, and 
immunocompetence(Rice, 1983).
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2.3 MAGNESIUM: INTAKE. UPTAKE & METABOLISM
2.3.1 D ietary Intake
Legumes, whole grains, nuts, meat, fish, eggs, peanut butter, cheese, milk, and fruit 
are rich sources o f Mg(Rice, 1983). Lukaski (1995) reports that examples o f foods with 
high M g content include spinach (Icup cooked = 150mg), beans and black-eyed peas 
(Icup cooked = lOOmg) and tofu (1 cup = 300mg). With a normal diet, 30-40% of the 
ingested Mg is absorbed through the jejunum and ileum (Altura & Altura, 1991a). 
Urinary analysis has revealed that waterborne Mg2+ is absorbed 30% better than dietary 
Mg. Additionally, there is considerable diumal variation in tMg status, with morning 
values being 50-70% lower. (Lowik, Groot, & Biimerts, 1982).
The absorption o f Mg2+ m ay be influenced by other dietary factors. Rice (1983) states 
that Vitamin D assists in the uptake o f Mg2+. Lukaski (1995) reports that excessive fibre 
intake may decrease Mg2+ due to a rapid intestinal passage time, resulting in a negative 
Mg2+ balance. Typical western diets, which are high in protein and/or fat, do not seem to 
adversely affect Mg2+ balance despite the fact that these diets are typically lower than 
the recommended daily intake (RDI) of 350mg of Mg/day (Rice, 1983). If an individual 
is not able to acquire sufficient Mg2+ from their diet, Mg2+ supplementation may be 
beneficial. Supplemental Mg2+ may be taken as gelatin capsules or tablets with Mg2+ 
salts. In general, Mg2+ salts have a fractional absorption of about 20% (Lukaski, 1995).
2.3.2 Absorption. Excretion &. Metabolism
The absorption o f  Mg2+ is dependent on intake, intestinal transit time and the
absorption o f water. Normally, approximately 40% o f  the dietary Mg2+ is taken in at the 
jejunum and ileum. This fractional values changes, however, with intake. At extremely 
low intakes, the fractional absorption of Mg2+ is increased to 65%; meanwhile, at 
extremely high intakes, the fractional absorption o f Mg2+ can be as low as 11% (Altura 
& Altura, 1991a).
Under normal circumstances, the kidney is the prime regulator o f Mg2+ balance in the 
body (Altura & Altura, 1984). Approximately, 70-80% of the plasma Mg2+ is filtered at 
the glomerulus, and 20-30% is reabsorbed in the proximal convoluted tubule. This 
reabsorption is reduced with antibiotics, diuretics, thyroxine, calcitonin, and 
hypercalcemia (Rice, 1983). Repetitious use o f antacids will increase Mg2+ levels
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beyond 2.5mmoI/L, becoming toxic. Several disease processes such as chronic diarrhea, 
diabetes mellitus, and renal tubular disorders may decrease Mg2+ (Elin, 1992).
Serum Mg2+ is maintained with a narrow range by the kidney and small intestine. In 
instances o f  magnesium depletion, both organs increase Mg2+ absorption to counter the 
imbalance. I f  depletion persists, bone stores give up Mg2+ to the plasma (Elin, 1992).
Serum magnesium levels (tMg or iMg) reflect not only kidney function, but also acute 
dietary changes. Either an increased/decreased intake and/or excretion are reflected in 
serum measures (Elin, 1992; Whang et al., 1994). For example, during a three-week 
period, 24 normal subjects consumed a low Mg diet and became Mg deficient (less than 
0.6mmol/L tM g in serum)(Whang et al., 1994). Additionally, magnesium status 
measures may not reflect direct intake, as levels are influenced by fat and calcium 
intakes. These serve to reduce Mg2+ levels in the blood (Seelig, 1994). Also, increases in 
insulin levels result in the shifting o f extracellular Mg2+, intracellularly (Altura & Altura, 
1996).
Finally, ethnicity and sex have been postulated to play a role in Mg homeostasis. 
Differences in iMg and tMg have been observed between both white and black 
hypertensive and normotensive populations (Resnick, Bardicef, Altura, Alderman, & 
Altura, 1997) suggesting that ethnicity may influence Mg metabolism. As well, Yamori 
et al. (1990) reported an inverse relationship between magnesium and blood pressure in 
women only. This might be attributable to differences in magnesium metabolism between 
men and women. Preuss (1993) reported that women retain magnesium better than men, 
and proposed estrogen as a possible explanation.
10
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.4 MAGNESIUM: DISTRIBUTION & ASSESSMENT
There is still much uncertainty as to the exact proportion and distribution of 
magnesium throughout the body. Total body stores are estimated between 21-28g (Elin,
1992). Approximately 60% is stored in bone, 20-27% in skeletal muscle, and less than 
1% o f total body magnesium is in the blood (of which. 0.3% is present in the serum) 
(Elin, 1992). These values are estimations as there is some flow between magnesium 
stores and the circulating extracellular environment. Extracellularly, magnesium is 33% 
protein bound, 12%complexed to anions, and 55% is in the free ionized form. Ionized 
magnesium (iMg) is the most important fraction as it represents the form o f magnesium 
that is physiologically active or available (Altura & Altura, 1991c; Elin, 1992). 
Previously, the assessment of magnesium has typically been based on total magnesium 
measures (tMg). Now, iMg can be distinguished from tMg (Altura &Altura, 1984).
Additionally, it should be mentioned that iMg levels do not always correlate with tMg 
levels in serum (Altura & Altura, 1996). Altura & Altura (1996) noted that even 
borderline hypertensives (140/90 to 150/95) usually exhibited significantly depressed 
iMg, but not tMg levels. This is a further argument for the use of iMg in the diagnostic 
assessment o f magnesium status as tMg levels are more consistently maintained. Al- 
Ghamdi et al. (1994) reports that tMg is maintained in a narrow range by the kidney and 
can be normal in the presence o f Mg2+ deficiency. If  depletion is severe enough, the 
Mg2+ will result in altered tMg values. The normal reference interval for the 
concentration of tMg in adults is 0.75-0.96mmol/L (Elin, 1992). Values below this are 
considered to be Mg2+ deficient Ionic Mg2+, however, is a more representative 
indicator o f magnesium status with intracellular values corresponding to those found in 
whole blood, plasma, and serum. As well, iMg appears to cross the cell membrane 
relatively quickly which would suggest that the two reservoirs are in dynamic equilibrium 
(Shirey, 1995). This has important implications when trying to assess whole body Mg2+ 
status, since, as stated previously, tMg measures are not reflective of intracellular 
concentrations. However, normal serum iMg values are not well established as ranges 
from 0.55-0.67 mmol/L have been reported by Elin (1992), and Ising et al. (1995) report 
a normal range o f 0.46-0.60 mmol/L. Ionic magnesium deficiency has also been defined
11
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by Elin (1992) as those less than 0.55mmol/L (Elin, 1992); whereas, Ising et al. (1995) 
states that values less than 0.45tnmol/L are deficient.
Magnesium levels can be assessed in various tissues such as serum, red blood cells, 
muscle, and mononuclear blood cells. Total magnesium content in one tissue may not 
relate to another. Also, magnesium can be assessed physiologically with balance, renal 
excretion, retention, and isotope studies. Now, most commonly, is the assessment of 
serum iMg. This can be determined using an ion-selective electrode (ISE), fluorescent 
indicators, or nuclear magnetic resonance spectroscopy (Elin, 1992). Use o f  ISE has 
become preferable in that accurate linear measurements o f iMg can be determined 
rapidly, without interference from other cations or trace metals (Altura & Altura, 1991c). 
Serum is generally used rather than plasma since the anticoagulant in plasma can 
contaminate or affect the assay (Elin, 1992).
2.5 MAGNESIUM AND BLOOD PRESSURE(BP): THE EVIDENCE
Recently, evidence from epidemiological, clinical, and experimental studies has 
accumulated that indicates that Mg has an important role in regulating ion transport and 
vascular tone and reactivity. As such. Mg deficiency may be an important etiologic factor 
in the development and treatment o f hypertension. These mechanistic processes will be 
discussed in section 2.6. Presented here, however, is a review of some o f  the evidence 
that links magnesium to blood pressure.
12
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2.5.1 Epidemiological
Interest in magnesium and its role in cardiovascular disease first arose in the 1950’s as
écologie studies around the world found an inverse relationship between water hardness 
and the incidence o f cardiac fatalities (Altura & Altura, 1991b; Whelton & Klag, 1989). 
At that time, it was reasonable to think that a “common factor” would explain such a 
trend. In recent years, the observation that magnesium contributes to water hardness and 
has known physiologic roles related to cardio-protection, has led to it becoming the link 
or “common factor” in the “water-story” (Anderson & Le Rich, 1971; Marier, 1985; 
Whelton & Klag, 1989).
Furthering these observations, comparisons between water hardness and blood pressure 
have been made. In 24 West Texan communities, Dawson et al. (1978) demonstrated an 
inverse relationship between drinking water magnesium, and hypertension (as cited in 
Whelton & Klag, 1989). While numerous investigations have been done at the 
community level, few studies have investigated the relationship between magnesium 
intake and blood pressure within individuals. The Honolulu Heart Study was performed 
at the individual level and found that 24 hour intake o f magnesium (as measured by 
dietary recall) was inversely related to blood pressure (Joffres, Reed, & Yano, 1987 as 
cited in Whelton & Klag, 1989). On a larger scale, an internationally cooperative study 
(CARDIAC: Cardiovascular Diseases and Alimentary Comparison), ex am in ing  the 
relationship between diet and blood pressure in 20 different countries concluded that 
dietary factors influence the genesis o f  hypertension. In this study, it was noted that 
magnesium had a beneficial effect on blood pressure (Yamori et al., 1990).
2.5.2 Clinical
Altura & Altura (1996) report that in 28 independent clinical studies, patients with 
hypertension exhibited decreased serum tMg. On average, the reduction in tMg was 15% 
fi"om normal. They further report that even borderline hypertensives (SBP/DBP=140/90- 
150/95) usually exhibit significantly depressed iMg, but not tMg. A variety o f such 
clinical studies, as well as observations from clinical experiences, support the idea that 
magnesium deficiency is linked to hypertension. Nevertheless, in clinical practice, oral 
magnesium therapy is still controversial as some studies fail to support this idea
13
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(Widman, Wester, Stegmayr, & Wirell, 1993). Outlined in the following are some o f 
these studies and their findings.
Lind, Lithell, Pollare, & Ljunghall (1991) performed a double blind, placebo 
controlled study, adding ISmmol of Mg to a free diet o f 71 subjects over six months. 
These subjects were classified as mildly hypertensive, or having high-normal blood 
pressure. They reported that the treatment, which elevated urinary magnesium excretion 
by 30%, induced no general effects on blood pressure. However, when the changes in 
blood pressure in the actively treated group were related to their pretreatment magnesium 
status, a correlation was found. In subjects with low pretreatment urinary excretion of 
magnesium, blood pressure was reduced. It was concluded that in general, magnesium 
supplementation does not seem to be effective in reducing blood pressure in unselected 
subjects with mild hypertension or high-normal blood pressures. However, in subjects 
with a low urinary excretion of magnesium, probably representing magnesium deficiency 
and/or a low magnesium intake, a hypotensive effect was seen.
In a study performed by Witteman et al. (1994), a  reduction in blood pressure was 
observed with oral magnesium supplementation in women with mild to moderate 
hypertension. In a double blind fashion, 91 women were assigned randomly to either a 
treatment or placebo group. The treatment consisted of 20mmol Mg/day o f magnesium- 
aspartate. At the end of the study, SBP had fallen by 2.7nunHg (p=0.18), and D B F  had 
fallen 3.4mmHg (p=0.003). In a similar study, Widman et al. (1993) performed a double­
blind cross-over study o f m agnesium  supplementation with 17 patients with D B P over 
90nunHg. Treatment consisted of receiving 15 mmol Mg2+/d for 3 weeks, 30 mmol 
Mg2+/d the following 3 weeks, and ended with 3 weeks o f  40 nunol Mg2+/d. A 
significant decrease in SB P was observed such that mean levels went fi-om 154+/-10.7 
m m H g  to 146+/-16.9 (p=0.031). D B P was also observed to significantly decrease fi-om 
100.2+/- mmHg to 92+/-6.6 mmHg (p=0.0001). (It should be noted that 15mmol Mg2+/d 
represents the RDA for men, while 13 Mg2+/d represents the RDA for women.)
The aforementioned studies support the idea that magnesium has a beneficial effect on 
blood pressure. Nevertheless, there are numerous studies which fail to demonstrate this 
relationship. Emerging from these investigations is a focus on initial magnesium status 
and the dosages o f magnesium used. In those studies showing a beneficial influence of
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magnesium supplementation, it may be likely that initial magnesium status was deficient, 
or that a pharmacologic dose o f  magnesium was used. In those studies failing to 
demonstrate a relationship, it may be that subjects were initially magnesium replete, or 
that non-pharmacologic (or “nutritional”) doses o f magnesium produce no effect. For 
example, Plum-Wirell, Stegmayr, & Wester (1994) performed a double-blind cross-over 
study, randomly assigning thirty-nine untreated hypertensive patients to either a treatment 
or placebo group. Treatment consisted o f 15 mmol/d o f  oral magnesium. No significant 
changes in blood pressure were observed and although urinary magnesium rose in the 
treatment group, no changes were seen in serum or muscle magnesium levels. While 
Plum-Wirell et al. (1994) noted that a high number o f patients had low muscle and serum 
magnesium at the start o f the study, there was, nevertheless, an obvious lack o f effect 
with the dose used. When comparing this to the work performed by Widman et al.
(1993), it seems that “nutritional doses” o f  magnesium (15 mmol/day) are insufficient to 
elicit an effect, as Widman reports blood pressure decreases with a treatment regimen that 
consisted of progressively higher Mg2+ doses (15, 30, & 40 mmol/day across 3 weeks.) 
Contrary to this, however, is the work o f Zemel et al. (1990) wherein pharmacologic 
doses o f 40mmol Mg-aspartate were administered. No effect was observed on blood 
pressure, however, it was indicated that these patients were magnesium replete at the start 
o f treatment. Similarly, Yamamoto (1995) reports a lack of blood pressure effect with 
magnesium supplementation in adults with high-normal blood pressure in a TOHP (Trial 
o f Hypertension Prevention) study involving 698 adults, hi this study, nutritional doses of 
360mg/day o f magnesium were used. In 1999, Burgess et al. investigated clinical trials, 
meta-analyses and review articles (taken from 1966-1999 on Medline) regarding the 
supplementation and consumption o f magnesium as treatment or prevention for 
hypertension. Their evidence-based recommendations concluded that magnesium 
supplementation is not recommended as a means o f preventing or treating an increase in 
blood pressure. They do, however, comment that most studies thus far have been short­
term and that no long-term studies have evaluated the effect o f increased intake of 
magnesium on morbidity or mortality rates. Additionally, most of these studies have 
involved dietary manipulations o f more than one cation, making it difficult, if  not 
impossible, to determine the influence o f one cation alone.
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Results from a variety o f clinical studies are difficult to compare as different 
doses o f  magnesium have been used and patients are divergent in both their degree o f 
hypertension and initial magnesium status. It is important to consider all o f these factors 
when evaluating the effectiveness o f magnesium as an anti-hypertensive agent. 
Nevertheless, most studies report finding a  suppressed iMg level in hypertensive 
individuals. The following table outlines representative iMg and tMg measures for 
normotensive and hypertensive individuals, taken from Resnick et al. (1994) as cited in 
Altura & Altura (1996).
Table 1 : iMg and tMg measures in normotensive and hvpertensive individuals:
N  iMg(mmol/L) tMg(mmol/L) iCa/iMg
Normotensive 61 0.62 ±0.007 0.88 ±0.01 1.96±0.03
Hypertensive 23 0.584 ±0.011* 0.82 ±0.02 2.13 ±0.04
*significant difference from  normotensive controls (p<0.01)
2.5.3 Experimental
Altura & Altura (1974) (as cited in Altura & Altura, 1985) performed in vitro 
experiments on rat aorta in order to determine whether graded changes in external Mg2+ 
concentration can affect the baseline tension o f isolated arteries and whether or not these 
changes also influence drug and hormone induced maximal contractile responses of 
vascular smooth muscle. Results from this study show a graded-response, wherein a 
greater reduction in Mg2+ extracellulary was observed with a greater mechanical 
response. Increasing Mg2+ was found to decrease basal tone and reduce contractile 
activity. This observation is explained on the basis o f Mg2+ competing for Ca2+ binding 
sites on the surface o f the vascular smooth muscle cell. (These processes will be 
elaborated upon in Section 2.6). In 1996, Altura & Altura report that further 
experimentation with rats demonstrated that dietary deficiency of Mg produced an 
increased arterial blood pressure, decreased arteriolar, venular, and pre-capillary lumen 
sizes with a simultaneous reduction in blood flow. Within the same study, iCa/iMg ratios 
were seen to increase in vascular wall, increasing vascular tone and enhancing reactivity 
to endogenous vasoconstrictors. Berthelot & Esposito (1983) report that a diet normal in 
magnesium content supplied to spontaneously hypertensive rats slowed the rate of 
progression o f hypertension as compared to those rats receiving a magnesium deficient 
diet.
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2.6 MAGNESIUM. CALCIUM. SODIUM & POTASSIUM: ROLES IN VASCULAR 
HEALTH
2.6.1 Mechanism by which M ineral Elements affect Blood Pressure
Increased vascular resistance accounts for raised blood pressure in most patients with
essential hypertension (Karppanen, 1991). Calcium, sodium, potassium and magnesium
play an important part in regulating this tension and the resistance to blood flow. These
mineral elements interact extracellularly, at the membrane, and intracellularly to
influence the vascular smooth muscle. Those interactions which result in a rise in
intracellular calcium ion concentration account for the increased resistance observed in
hypertensive individuals as there is a  greater association o f calcium with calmodulin
(Karpaimen, 1991). This, in turn, triggers a cascade o f events as the calcium-calmodulin
complex activates myosin light chain kinase to phosphorylate the myosin head, enabling
the binding o f actin and the subsequent contraction of the vascular smooth muscle (Ives,
1989). The following outlines the main mechanisms by which an increase in intracellular
Ca2+ is brought about and influenced by other ions.
1 ■ Ca2+ Channels at the Membrane
One factor increasing the level o f  calcium in the vascular smooth muscle cell is the
action potential. This opens voltage operated calcium channels and allows the entry of
calcium ions from the extracellular space into the intracellular space. Vasoconstrictor
agents such as noradrenaline, angiotensin II and serotonin increase the concentration of
intracellular calcium ions by opening receptor operated calcium channels (Fig.l)
(Karpannen, 1991). A  rise in extracellular calcium concentration will increase
intracellular concentrations, and Karpannen (1991) reports that this is observed with a
concurrent increase in blood pressure. Antihypertensive drugs (such as nifedipine) act to
block Ca2+ binding and entry into the vascular smooth muscle cell. Evidence has
accumulated to indicate that extracellular Mg2+ can regulate Ca2+ binding sites, and
thus, influence the control o f arterial tone and blood pressure. Altura & Altura (1996)
elaborate on direct and indirect experimentations that have shown Mg2+ is a Ca2+
antagonist, competing for both membrane and intracellular binding sites. This decreases
Ca2+ binding, entry and translocation in the vascular smooth muscle cell, causing
vasodilation and lowering blood pressure. Conversely, it has been observed that a
17
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reduction in extracellular Mg2+ corresponds to an increase in intracellular Ca2+ content 
and elevated blood pressure (Altura & Altura, 1984,1985).
In addition to influencing basal tone, Mg2+ also affects the reactivity o f smooth 
muscle to catecholamines, as well as the release o f catecholamines. Seelig (1994) 
reviewed experimental findings where the removal o f Mg2+ from the external 
environment enhanced the reactivity o f small and large coronary vessels to 
catecholamines, angiotensin H, serotonin, and acetylcholine. Conversely, the action of 
coronary relaxants such as vasopressin and prostanoids, were greatly attenuated as Mg2+ 
was reduced. Seelig (1994) reported that when immersed in solutions with high or low 
Mg2+/Ca2+ ratios, catecholamine secreting granules from adrenal medulla or nerve 
endings, release less or more catecholamine, respectively. This makes Mg2+ an important 
player iu stress reactions as deficiency promotes such a release. Elevations in 
catecholamines will result in increased lipolysis, availing free fatty acids (FFA) to the 
blood. These FFA bind to Mg2+, soaking it up in a sponge-like fashion, reducing iMg 
levels and furthering exacerbating Mg2+ status (Seelig, 1994). From the aforementioned 
observations o f Mg2+’s influence on basal tone, reactivity and catecholamine release, it 
has been compared to verapamil, a pharmacologic Ca2+-channel blocker. This makes 
Mg2+ a physiologic Ca2+-channel blocker (Seelig, 1994).
18
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Figure 1: The role o f  calcium (Ca2+), potassium (K+), and sodium (Na+) ions, 
as well as the Na+-K+-pump, Ca2+-Na+ exchange mechanism, and Ca2+ 
channels in the regulation o f vascular smooth muscle contraction. The sites o f 
action o f magnesium ions (Mg2+) as activators o f the Na+-K+-piunp and as 
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2. Na+-K+ ATPase Pump and Na+-Ca2+ Exchange Sites frefer to preceding Fig.H 
Sodium excess in the body, due to a  high intake or impaired elimination, may increase
the level o f  endogenous Na+-K+ATPase inhibitors, also called digitalis like agents
(Karpannen, 1991). Similarly, a decrease in Mg2+ will reduce the activity o f Na+-
K+ATPase as it has an obligate dependence on Mg2+-ATP (Karpannen, 1991). Inhibition
o f  Na+-K+ATPase in either instance, will increase the intracellular Na content. As a
consequence o f raised intracellular sodium content, the activity o f the Na+-Ca2+
exchange mechanism falls, increasing intracellular Ca2+ content (Karpannen, 1991).
Therefore, the inhibition o f the Na+-K+ATPase, either thm increase Na+ or decreased
M ^ + , results in increased intracellular Ca2+ levels, inducing contraction o f the vascular
smooth muscle, and raising blood pressure. A  rise in potassium can reactivate the Na+-
K+ATPase, exerting an anti-hypertensive effect (Karpannen, 1991).
3. CAMP levels and Ca2+-ATPase Extrusion o f Ca2+
Altura & Altura (1985) reported that the influence o f Mg2+ on vascular muscle tone
and reactivity could also be explained in terms o f an effect on adenosine 3’,5’- 
monophosphate (cAMP) formation with the cells. The synthesis o f cAMP is dependent 
on the activity o f adenylate kinase, an enzyme that is activated by Mg2+. They further 
report that some experimental evidence suggests that increased and decreased cAMP 
levels participate in vasodilation and vasoconstriction, respectively. A decreased cAMP 
level, resulting from an insufficient Mg2+ activation o f adenylate kinase, could result in 
an increase in the concentration o f  Ca2+ in the cytoplasm as there is less cAMP mediated 
Ca2+ sequestration. Altura & Altura (1985) report that an alternative mechanism has 
been proposed wherein a Mg2+ dependent Ca2+-ATPase could be inhibited with low 
available Mg2+. This Ca2+-ATPase would be responsible for extrusion of Ca2+ at the 
membrane.
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4. Mg2+-Induced Alterations in Vascular Muscle Ion Permeability
Altura & Altura (1985) report that evidence has accumulated that Mg2+ not only acts
as a regulator o f the entry and exit o f  Ca2+, but can also alter membrane permeability to
other ions. Experimentation with the removal o f Mg2+ from the extracellular
environment has caused the membranes to become “leaky”, allowing divalent and
trivalent cations ( Be2+, Fe3+, AJ3+) with atomic radii smaller than Mg2+, to gain access
to the cytoplasm. These, in turn, promote the release o f intracellular Ca2+.
2.6.2 An Integrated Hypothesis fo r  the Magnesium/Hypertension Relationship 
Altura & Altura (1985) propose a hypothetical schema for the development o f
hypertension in the presence o f  dietary and metabolic Mg2+ deficits. This schema
integrates the aforementioned mechanisms for the regulation of vascular tone. In
particular, it focuses on Mg2+-Ca2+ and Na+-Ca2-f- exchange sites as regulators of
vascular tone, blood pressure, and local blood flow. The following (Fig. 2) is a
representation of this integrated hypothesis.
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Figure!: Hypothetical schema for the dysfunction o f normal cardiovascular tone by 
deficits in dietary Mg intake, or, inadequate metabolism o f Mg2+. Diagram adapted 
from page 134, Altura & Altura (1985).
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2.6.3 Magnesium and Arteriosclerosis: Lipid Hypothesis
Morrill et al. (1997) commented that the accumulated epidemiological data that relates
geographic regions o f  low magnesium content (soft water and Mg-poor soil) with high 
incidences o f ischemic heart disease (IHD) and sudden cardiac death (SCD,) might be 
explained by a Mg2+ etiology for arteriosclerosis and cardiovascular disease. This is 
supported by the observation that the coronary arteries o f such patients often show 
deficits o f 30-40% in total magnesium content and a simultaneous elevation in Ca2+ 
content(Morrill et al, 1997). Altura & Altura (1985) also report that several studies, in 
both animals and man, indicate an inverse relationship between cholesterol concentration 
and magnesium level. It is known, that at least experimentally, it is possible to prevent 
atheroma formation by increasing the dietary intake o f Mg (Altura & Altura, 1985). 
Furthermore, magnesium salts have been shown effective in the clinical treatment of 
several cardiovascular diseases (arrhythmias, hypertension, myocardial infarction) 
(Morrill et al.,1997).
Etiologically, Altura & Altura (1985) comment that the development of 
atherosclerotic plaques is Ca2+ dependent. Since Mg2+ is a competitive inhibitor of 
Ca2+ on vascular smooth muscle, one must consider that elevations in dietary Mg may 
aid in preventing arteriosclerosis. Morrill et al. (1997) also found that lipid oxidation of 
vascular smooth cells was increased with decreasing Mg2+ concentrations 
extracellularly. This suggests Mg2+ acts as an anti-oxidant, protecting endogenous 
membrane lipids from free radical attack. This is important as disruptions to the intimai 
smooth muscle membrane precedes the development o f intermediate atherogenic lesions 
(Morrill et al., 1997). Haennie et al. (1999) reports that an inverse relationship with 
atherogenic lipid fractions and magnesium levels, was more evident using iMg than tMg. 
This indicates that iMg may be a more relevant and important measure when studying the 
relationship between serum electrolytes and lipoproteins.
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2.7 HYPERTENSION: LIFESTYLE AND DIETARY RISK FACTORS
2.7.7 Hypertension Defined
Hypertension is the most prevalent risk factor for premature cardiovascular disease,
and since cardiovascular diseases are the leading cause o f  death in all industrialized 
countries, hypertension can be called our major public health problem (Kaplan, 1986). 
The total estimated number o f hypertensive people in the United States totaled 30 million 
as reported in 1986 by Kaplan. In Canada, our 1986 estimate for the number of 
hypertensive individuals under 70 years o f age was 1.25 million as reported by Stephens, 
Craig & Ferris (1986). Gentleman and Tomiak (1992) further report that large numbers 
o f  C anadians have high blood pressure but do not have their condition under control or 
have not yet identified it. In 1993, Tomiak & Gentleman performed a study o f the risk 
factors for hypertension through the Canada Health Survey. In this report, normal blood 
pressure was defined as having a DBF <90 and a SBP <140. An elevated blood pressure 
was defined as having a DBF >95 or SBF>160. Intermediate to these two definitions is 
what is defined as borderline hypertensive. These definitions are consistent with other 
sources. It should be noted, however, these definition are based on adult norms.
Hypertension can be identified in children and adolescents, although it is less 
prevalent and the absolute levels of BF differ from those o f adults(Falkner & Sadowski, 
1995). Falkner & Sadowski (1995) define hypertension as having systolic or diastolic BF 
measures that are repeatedly above the 95th percentile for age and sex. Table 2 outlines 
such percentile norms for SBF and DBF in males and females aged 20-29 as determined 
from the 1981 Canada Fimess Survey (Stephens, Craig, & Ferris, 1981). These 
percentiles allow for the appropriate consideration o f BF values in younger subjects.
24
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Table 2: fadapted from Stephens. Craig. & Ferris. 19811 













Tomiak and Gentleman (1993) examined risk factors for hypertension, as measured by 
the Canada Health survey. Their analysis showed that age, sex, genetic history, and body 
mass index were the most important factors in predicting high blood pressure. For males, 
degree o f physical activity and blood cholesterol levels were other predictive factors. In 
females, marital status and family income had significant associations with hypertension. 
The risk for high blood pressure in individuals smoking more than 10 cigarettes a day 
was found to not be significantly different than those who have never smoked. Tomiak & 
Gentleman (1993) report that this observation is consistent with other studies, which have 
shown no relationship between blood pressure and smoking, adding that it is, however, 
important to recognize smoking is closely related to coronary artery disease.
Additionally, the amount o f alcohol consumed was shown to have no significant 
association with BP measures. This observation is countered in Kaplan (1986), reporting 
that experimental and epidemiological work indicates that blood pressures are 
progressively higher with increasing alcohol consumption. Kaplan (1986) suggests that 
chronic alcohol intake may exert chronic pressor actions. Furthermore, it is suggested that 
alcohol in more than moderate amounts (2 oz/day) may raise blood pressure enough to 
make it the most prevalent cause of reversible hypertension. Kaplan (1986) also 
discusses caffeine, indicating that it raises blood pressure acutely, but its intake has not 
been clearly associated with the induction o f permanent hypertension.
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2.7.3 D iet as Therapy
Kaplan (1986) states that changes in diet are advocated for those who are
hypertensive. This recommendation is not only based on the observation that dietary
changes have corresponded to reductions in blood pressure, but due to the fact that the
use o f anti-hypertensive drugs present additional risks while reducing the elevate blood
pressure. Kaplan (1986) also furthers that although evidence for the anti-hypertensive
efficacy o f  dietary change rests largely on epidemiological or methodologically weak
studies, these changes should be considered; they “should do no harm to those who do
not need them, and may provide a great deal o f  benefit to those who do.” Kaplan(1986)
concludes that “non-pharmacologic approaches be used as definitive intervention and as
and adjunct to drug therapy.” The following section discusses the different dietary targets
for blood pressure control, including both micronutrient and macronutrient components.
1. Micronutrient Intakes: Na. K. Ca. and Mg
The experimental and epidemiological evidence relating a high sodium intake to the
development o f hypertension is strong, showing that a marked reduction in sodium intake
decreases blood pressure significantly and vice versa (Kaplan, 1986).The latter has been
called Na+-induced hypertension and it results in an expansion of the extracellular
volume as Na+ and water accumulate. In turn, there is a concomitant rise in BP. What has
emerged in more recent studies, however, is that there is a strong genetic factor relating
to sodium sensitivity and the development o f  Na+-induced hypertension (Preuss, 1993;
Muntzel & Drueke, 1992). That is to say that some individuals may be salt sensitive, and
others may not. Muntzel & Drueke (1992) report that dietary salt restriction generates
variable blood pressure responses in different individuals. These differences are mediated
through either intrinsic or indirect alterations in renal function (Preuss, 1993). In  other
words, the kidney may possess inborn defects for sodium excretion, or may have a
reduced response to ANF (atrial natriuretic factor), which acts to eliminate sodium
(Muntzel & Drueke, 1992). So, while all hypertensives do not benefit from a reduced
sodium intake, there is no apparent potential for harm fi"om moderate sodium restriction
to a level o f  75-1 OOmmol/day and it is therefore recommended as part o f dietary
treatment (Kaplan, 1986).
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Many o f  the reported benefits o f  a reduced sodium intake may reflect an increased 
potassium intake (Kaplan, 1986). Generally, whenever sodium is deleted firom the diet by 
substitution o f  natural foods for processed food, potassium intake increases. Kaplan 
(1986) further comments that a high K+/Na+ ratio is an important in factor in the 
prevention o f  hypertension. Preuss (1993) also reports that many clinical studies show 
that an increased K  consumption lowers BP significantly, and that an inverse relationship 
between K  intake and BP have been shown in several epidemiological studies. Burgess et 
al. (1999) considers several intervention studies, however, and notes that these failed to 
demonstrate that potassium supplementation prevents an increase in blood pressure. 
While it has been suggested that K+ acts to activate the Na+-K+ ATPase pump, thereby 
reducing intracellular Ca2+ and vascular smooth muscle contraction(Karpaimen 1991), 
Burgess et al. (1999) states that the evidence does not support potassium supplementation 
for normotensive people as a prevention for hypertension.
Too much calcium in the blood or vascular tissue may be involved in the pathogenesis 
o f hypertension as increased peripheral vascular tone results firom elevated intracellular 
Ca2+ levels (Kaplan, 1986). Nonetheless, the intake o f too little, not too much, calcium 
may be associated with hypertension, and oral supplements may lower, not raise, blood 
pressure (Kaplan, 1996). In a meta-analysis o f 33 Ca supplementation studies, Bucher et 
al. (1996) concluded that supplementation may lead to a small reduction in SBP, but not 
DBP. Preuss (1993) also reports that low dietary intakes o f Ca have been postulated to 
increase BP, suggesting that intakes below 400-600mg/day o f dietary Ca is associated 
with a greater risk o f hypertension, whereas intakes above this threshold are associated 
with less risk. One explanation that has been proposed, suggests that the hormones 
responsible for m ain ta in ing  Ca2+ homeostasis modulate vascular Ca2+ uptake (Bukoski 
&  Kremer, 1991). For example, a decrease in serum Ca2+ results in the release of 
parathyroid hormone (PTH) from the parathyroid gland. In turn, this results in the 
production o f 1,25-dihyroxycholecalciferol from the proximal convoluted tubule. This 
promotes Ca2+ uptake and contraction (Bukoski & Kremer, 1991). Nevertheless, as 
Burgess et al. (1999) report, intervention studies have failed to demonstrate that calcium 
supplementation prevents increases in blood pressure in normotensive people or assists in 
the treatment o f hypertensive individuals. Preuss (1993) concludes that there is no good
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way to predict how patients may respond to augmented Ca intake. Accordingly, no 
additional intake above the RDA o f 800-1200mg/day is recommended.
As discussed more substantially in the preceding sections. Mg deficiency may 
contribute to the development o f  hypertension. Thus, oral replacement could potentially 
be of benefit (Preuss, 1993). Kaplan (1986) reports that magnesium plays a major role in 
the control o f vascular tone, causing vasodilation when infused into human subjects. 
Nevertheless, experimental and epidemiological studies have not come to conclusive 
recommendation for the use o f  dietary Mg as an anti-hypertensive agent. Burgess et al. 
(1999) notes that epidemiological studies have not reliably or consistently shown a 
relation between magnesium intake and blood pressure. It is concluded from this work, 
that supplementation with magnesium has not yet demonstrated a beneficial effect for the 
prevention or treatment o f  hypertension.
2. Caloric & Macronutrient Intakes: Fat. Protein, and Carbohvdrate
Calories are very important in battling the development o f hypertension. Weight
and/or body mass index, in association with age, are the strongest correlates of BP 
(Preuss, 1993). The relative risk o f developing hypertension is 5-6 times higher in obese 
adults than that o f lean individuals (Preuss, 1993). Preuss (1993) reports that obesity, 
more prevalent in females, is associated with many perturbations that promote elevations 
in BP. These perturbations include increased sympathetic nervous system activity and the 
excess intake o f  nutrients, which influence pressure, elevate cardiac output and increase 
insulin resistance. Kaplan (1986) also reports that people with a body weight 20% or 
more above ideal have a firequency of hypertension about two times higher than do the 
non-obese. Furthermore, Kaplan (1986) states that although few studies have dissociated 
weight loss firom sodium restriction, the evidence is strong supporting dietary restriction. 
In more recent time, however, Preuss (1993) comments that studies have dissociated the 
two and have indicated that even modest weight loss, in the absence of sodium 
restriction, is associated with a significant lowering o f BP.
While calories are significant in relationship to BP, so is the manner in which caloric 
intake is proportioned across fat, carbohydrate, protein, and fibre intakes. Kaplan (1986)
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and Preuss (1993) report that BP may fall in response to a decrease in total fat, along with 
an increase in polyunsaturated fat. The anti-hypertensive effect o f  polyunsaturated fatty 
acids, such as linoleic acid, has been assumed to be mediated b y  way o f an increased 
synthesis o f  vasodilatory prostaglandins (Preuss, 1993). As for carbohydrate intake, 
Preuss (1993) reports that current evidence indicates excess refined carbohydrate 
consumption increases BP, while complex carbohydrate and soluble fibre consumption 
lowers BP. Ascherio et al. (1991) also supports the observation that an increase in fibre 
intake is associated with decreased BP, finding an inverse relationship between dietary 
fibre and DBP in a study o f nutrient intakes o f  normotensive males. Little information is 
available on the influence o f protein intake on BP, although Yamori et al. (1990) reported 
in their internationally cooperative study on diet and blood pressure, that animal protein 
was inversely correlated to BP. This supports the recommendation made by Kaplan 
(1986) that advocates a return to the ancestral diet o f man, which our physiology is likely 
best adapted and evolved to handle. This ancestral diet was higher in protein and 
potassium content, while lower in fat and sodium content. Kaplan (1986) also reports a 
study that illustrates a vegetarian diet may lower blood pressure. The ingredients o f a 
vegetarian diet that may lower blood pressure are presumed to be  an increased content o f 
polyunsaturated fat, fiber, vegetable protein, potassium, and magnesium.
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2.7.4 Recommendations fo r  the Prevention and Treatment ofHypertension
Kaplan (1986) made recommendations for a practical dietary prescription for the 
prevention and treatment o f  hypertension. It is likely these recommendations are relevant 
today. The following is a list o f  those recommendations;
1. For the overweight, weight reduction should be the primary goal.
2. For all hypertensives, dietary sodium should be restricted to a 2g daily level.
3. Potassium intake need not be specifically iucreased since it will rise with a lowered 
sodium intake. Those who are hypokalemic may benefit from potassium 
supplementation.
4. Supplemental magnesium and calcium is recommended for those who are deficient. 
Caution is advised in not reducing the dietary sources o f calcium when dietary sodium is 
reduced.
5. More fibre and less saturated fat are beneficial for other reasons and may also help to 
lower BP.
6. Alcohol should be limited to 2 oz/day.
2.8 SUMMARY
In summary o f  the literature, it seems that the protective influence o f dietary Mg on 
BP in normotensive individuals has not been reliably or consistently established. It may 
be that this measure does not accurately reflect the physiologically relevant blood ionic 
measures o f magnesium. Furthermore, Mg supplementation in hypertensive individuals 
has not been shown to consistently reduce BP. In these instances, it seems important to 
consider an individual’s initial magnesium status (iMg) as hypotensive effects are 
generally only observed in those subjects that were deficient before treatment.
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CHAPTER THREE: METHODS
3.1 SUBJECTS
The sample was comprised o f 201 (82 males; 119 females) Lakehead University 
students enrolled in the Kinesiology program. The average age of the subjects was 21.4 
for males and 20.9 for females. The sample was physically active and 
asymptomatic(noimotensive). Ten subjects were smokers.
3.2.PROCEDURES
Subjects were involved in a one-hour testing session and asked to return a three- 
day dietary record the following week. Testing was comprised of three BP measurements, 
a blood sample, height and weight measurement, and the completion o f  a PAQ (physical 
activity questionnaire).
According to the Canadian Physical Activity Fimess and Lifestyle Assessment 
(CPAFLA) recommendations on BP assessment, subjects were asked to refrain from 
strenuous exercise for 24 hours prior to testing and to refrain from caffeine and alcohol 
consumption 6 hours prior to testing. Additionally, smoking habits were documented and 
subjects were asked to abstain from smoking at least 2 hours before the test. They were 
also advised to consume a light carbohydrate meal 2-3 hours prior to reporting to their 
test. One graduate student took all resting blood pressure measures with a random-zero 
sphygmomanometer. After 10 minutes o f sitting rest, 3 SBP/DBP were taken with 2 
minutes of intervening rest between measures. The mode score o f these three measures 
was used in reporting BP and the calculation o f MAP. In cases where all three measures 
differed, the median score was used.
Blood samples were taken following BP measures and obtained by an experienced 
phlebotomist. Collection was performed by antecubital venipuncture (Pendergraph, 1984) 
in a 7 mL heparinized Vacutainer tube. The multi-test Stat Profile Ultra Analyzer model 
11-3C (Nova Biomedicals Canada Ltd., Mississauga, Ont.) was used for the immediate 
analysis of iMg, iNa, iK, iCa, and hematocrit o f a 25ug sample of whole blood. 
Measurements were performed by the same technician throughout the study.
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Following the blood sample, a PAQ was filled out and height and weight were 
measured for the calculation o f subject body mass index (BMI). Three day dietary 
records (including one weekend day) were submitted by the subjects the following week. 
Diets were analyzed using software by NutriQuest (McGraw-Hill, 1998).
3.3 DATA ANALYSIS
Comparisons between the estimates o f  BP and dietary and blood ionic measures o f
Mg, Ca, Na, and K  were performed to examine significant differences (McNemar chi-
square), as well as significant associations (kappa test). In order to conduct these tests,
all BP, dietary and blood ionic values were transformed into dichotomous scores relative
to the median score for each variable. Those scores less than the median score for that
variable were assigned a value o f 1, while those scores at or above the median, were
assigned a value of 2. For all possible pair-wise comparisons between BP (SBP, DBP,
MAP) and dietary and ionic Mg, Ca, Na, and K, as well as BMI and physical activity, a
2X2 fiequency table was generated using statistical analysis software (SAS). This was
performed across the total group, as well as by sex. For all cases yielding significant
differences by McNemar z scores (z > 1.96 ), Relative Risk (RR) and Odds Ratio (OR)
were calculated. (See Appendix CJ)»E for sample calculations o f the McNemar chi-
square, kappa test, RR, and OR.)
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CHAPTER FOUR: RESULTS
4.1 DESCRIPTION OF SUBJECTS
The demographic characteristics o f the subjects are presented in Table 3. Hematologic 
and dietary characteristics are presented in Tables 4 and 5.
Table 3: General characteristics of subjects.
Parameter Males(n=82) Males(n=82) Females(n=119) Females(n=119)
Mean+SD Range Mean+SD Range
Age(years) 21.39 +1.56 19- 27 20.89 ±1.60 18 -33
BMI(kg/m2) 25.40 +3.88 14.0- 39.1 23.46 +3.25 17.2 -34.6
SBP(mmHg) 122.29 +7.35 106- 142 113.41 +7.80 94 - 140
DBP(mmHg) 76.51 +7.14 62- 92 71.9 +7.85 54 -9 4
MAP(mmHg) 91.77 ±6.10 81 - 105 85.74 ±6.75 69 - 103
Activity Score 4.52 +.61 2 - 5 4.36 ±.65 2 -5
Table 4: Hematologic characteristics o f subjects compared with “normative” measures.
Parameter “Normal’Values
Males(n=82) Males(n=82) Females(n=l 19) Females(n=l 19)
Mean +SD Range Mean +SD Range
iMg (mmol/L) 0.46-0.60= 0.488 + 0.030 0.420 - 0.550 0.490 + 0.032 0.410 - 0.580
iCa (mmol/L) 2.1-2.6*’ 1.27 + 0.037 1.18- 1.34 1.26 + 0.039 1.18--1.35
iNa (mmol/L) 135-145*’ 145.0 + 2.16 140- 150 144.7 + 2.03 140--150
iK (mmol/L) 3.5-5.0*’ 3.993 + 0.267 3.2- 4.9 3.913 + 0.247 3.4--5.0
iCa/iMg / 2.60 + 0.147 2.27- 2.95 2.59 + 0.1582 2.19--3.02
iNa/iK / 36.49 + 2.56 28,98 - 46.25 37.12 + 2.25 29.60 -42.94
a- Taken from Ising et al. (1995) 
b- Taken from Van de Graff & Fox (1995)
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4.2 STATISTICAL RESULTS
All possible pairwise comparisons between measures o f BP (SBP, DBP, MAP) and 
measures o f magnesium, calcium, potassium, and sodium (dietary and blood ionic) were 
performed by total group and sex. This was also performed for BMI (body mass index) 
and PAS (physical activity score on standardized CPAFLA questionnaire). RR (risk ratio) 
and OR (odds ratio) were determined for significant McNemar Chi-square (z>1.96) 
values. The following tables summarize these results. Findings with both significant 
McNemar z-scores and kappa associations are highlighted for discussion.
4.2.1 Blood Pressure & Blood Ions
Table 6 :  2X2 Comparisons o f  BP (SBP.DBP. MAP) and Blood Ionic measures 
(M ^^.C c^^.N a^.It.C c^^/M ^^. & Nà^/lC) bv Total Group.








DBP-Na"^ 50 49 30 72 2.14* 3.068* 0.2117* 1.59* 2.45*
DBP-K+ 68 31 75 27 4.27 / / 0.88 1.79
SBP-K+ 67 27 76 31 4.83 / / 1.00 1.01
MAP-K* 62 24 81 34 5.56 / / 1.03 1.08
MAP-
Ca^+/Mg^+
48 38 59 55 2.13 / / 1.07 1.18
SBP-Na'"/K'" 52 42 71 36 2.73 / / 0.80 0.63
DBP-Na^/K"" 60 39 63 39 2.38 / / 0.97 0.95
MAP-Na'^/K*' 50 36 73 42 3.54 / / 0.90 0.80
Note: A B C D  cells refer to low/low, low/high, high/low, and high/high comparisons of 
BP with blood ion measures, respectivelv. Determination of a “low” or “high” 
classification was based on the position relative to the median split for each variable.
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Table 7 : 2X2 Comparisons o f BP (SBP.DBP. MAP) and Blood Ionic measures 
IMs^\Ca^\Na\ir.Ca^'^/ME^+ & NaVK^ separated bv Sex.
Comparison A B C D McNemar K appa Probability Risk Odds
(z-score) (z-score) Ratio Ratio
M ALES
SBP-Mg^"^ 9 8 35 3 4.12 / / 0.99 0.96
MAP-M ÿ^ 12 8 32 30 3.79 / / 1.08 1.40
MAP-Cp^ 12 8 26 36 3.09 / / 1.20 2.08
SBP-Na+ 7 10 22 43 2.12 / / 1.07 1.37
SBP-K+ 10 7 40 25 4.81 / / 0.98 0.89
DBP-K^ 17 12 33 20 3.13 / / 1.09 0.86
MAP-îC 13 7 37 25 4.52 / / 1.06 1.25
SBP- 11 6 31 33 4.11 / / 1.15 1.95
Câ +ZMĝ -̂
MAP- 11 9 31 30 3.48 / / 1.04 1.18
Ca '̂"/Mg2‘"
FEM ALES
SBP-M^"" 37 40 23 19 2.14 / / 0.84 0.76
SBP-Ca^^ 39 38 21 21 2.21 / / 1.02 1.01
SBP-Na"" 33 44 18 24 3.30 / / 1.00 1.00
DBP-Na* 36 34 15 34 2 .71* 2.26* 0.197* 1.48* 2.40*
MAP-Na* 34 32 17 36 2.14* 2.13* 0.189* 1.59* 2 .25*
DBP-K^ 51 19 42 7 2.94 / / 0.60 0.44
MAP-K"" 49 17 44 9 3.46 / / 0.73 0.59
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4.2.2 Blood Pressure & Dietary Minerals
Table 8 :  2X2 Comparisons o f  BP (SBP.DBP. MAP) and M ineral Intakes(M^.Ca.Na.K) 
bv Total Grouv.








SBP-K 85 9 91 16 -8.2 / / 1.24 1.66
DBP-K 84 15 92 10 -7.44 / / 0.76 0.61
MAP-K 74 12 102 13 -8.43 / / 0.90 0.79
SBP-Mg 89 5 98 9 -9.16 / / 1.23 1.82
DBP-Mg 94 5 93 9 -8.89 / / 1.30 1.78
SBP-Na 84 10 83 24 -7.57 2.20* 0.112* 1.40* 2.43*
DBP-Na 82 17 85 17 -6.73 / / 1.00 0.96
MAP-Na 76 10 91 24 -8.06 / / 1.30 2.00
Table 9: 2X2 Comparisons o f BP (SBP.DBP. MAP) and M ineral Intakes(Me.Ca.Na.K) 
separated bv Sex.
Comparison A B C D M cNemar K appa Association Risk Odds
(z-score) (z-score) Ratio Ratio
M ALES
DBP-K 24 5 45 8 -5.66 / / 0.94 0.85
DBP-Na 19 10 39 14 -4.14 / / 0.87 0.68
MAP-Na 15 5 43 19 -5.48 / / 1.14 1.32
FEM ALES
SBP-K 71 6 36 6 -4.63 / / 1.49 1.97
MAP-Na 61 5 48 5 -5.91 / / 1.13 1.27
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4.2.3 Blood Pressure, BMI, and Physical Activity
Table 10: 2X2 Comparisons o f  BP (SBP.DBP. MAP) with BM I and Physical Activity 
Score bv Total Group and Sex
Comparison A B C D McNemar Kappa Association Risk Odds
(z-score) (z-score) Ratio Ratio
TOTAL
SBP-Act 5 89 5 102 8.66 / / 1.07 1.14
DBP-Act 5 94 5 97 8.94 / / 1.02 1.03
MAP-Act 5 81 5 110 8.20 / / 1.15 136
SBP-BMI 86 8 74 33 -7.29* 3.89* 0.214* 1.74* 4.79*
DBP-BMI 87 12 73 29 -6.62* 2.89* 0.161* 1.55* 2.88*
MAP-BMI 80 6 80 35 -7.98* 4.07* 0.212* 1.71* 5.83*
M ALES
DBP-BMI 23 6 34 19 -4.43 / / 1.27 2.14
FEM ALES
SBP-BMI 72 5 31 11 ^ 3 3 * 3.02* 0.229* 2.28* 5.10*
DBP-BMI 64 6 39 10 -4.92 / / 1.65 2.70
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CHAPTER FIVE: DISCUSSION
5.1 BLOOD PRESSURE. BLOOD IONS ( Mg2+. Ca2+. K+. & Na+). AND DIETARY 
MINERALS
The protective influence o f magnesium on blood pressure, as suggested by Whelton 
and Klag (1989), Shirey (1995), and Altura and Altura (1996,) was not demonstrated for 
the dietary measures in the present study. Although such results are contrary to some 
studies, these findings are consistent with Burgess et al. (1999). Using a meta-analytic 
approach, Burgess et al. (1999) showed across eighteen epidemiological and clinical 
studies, that magnesium intake had no demonstrable effect on BP. From this analysis, it 
was concluded that the benefit o f  magnesium supplementation for either the prevention 
or treatment of hypertension, has not been established.
While Burgess et al. (1999) found no evidence for the benefit of dietary magnesium, 
the results o f Widman et al. (1993) and Lind et al. (1991) suggest that magnesium may 
be found to be effective as a hypotensive agent in iMg deficient individuals. Widman et 
al. (1993) and Lind et al. (1991) reported that the treatment of hypertensive individuals 
with magnesium induced no general effects on blood pressure until corrected for 
pretreatment iMg status. Both studies concluded that supplementation is not effective at 
influencing BP in magnesium replete subjects. Findings in the present study are 
consistent with this conclusion as most subjects were determined to be within a normal 
iMg range of0.450-0.60mmol/L (Ising et al., 1995), and no demonstrable relationship 
with BP was found. The conclusions made by Burgess et al. (1999) may reflect that the 
iMg status o f subjects was not considered, and that dietary measures o f  Mg may not 
reflect physiologically relevant iMg. Furthermore, it may also indicate that the subjects 
involved were not compromised as to their iMg status.
While magnesium may not prove to be a target for hypertension prevention, evidence 
suggests that dietary sodium is such a target. In the present study, comparisons of dietary 
and ionic sodium with BP indicated a detrimental association. The chance o f having 
elevated DBP was over one and a half times greater for those with increased iNa as 
shown by the RR for the total group. The effects of iNa on DBP and MAP for females, 
and that of dietary sodium on SBP for the total group, were also found to be detrimental
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by RR. In all cases, the kappa statistic indicated a significant association between sodium 
and BP. That is to say that low measures o f  BP were associated with low measures o f 
sodium, and conversely, high measures o f BP were associated with high sodium 
measures. These findings are consistent with numerous epidemiological studies that link 
sodium to hypertension (Karpannen, 1991; Muntzel & Drueke, 1992; Preuss, 1993). It is 
believed that this link is the result o f  the expansion o f  the extracellular volume as Na+ 
and water accumulate p reuss, 1993) or due to an increase in endogenous Na+- 
K+ATPase inhibitors (Karpannen, 1991). These inhibitors (digitalis-like) reduce the 
activity o f the Na+-K+ pump, causing a rise in intracellular Na+ and a slowing of Na+- 
Ca2+ exchange. As a consequence, intracellular vascular smooth muscle Ca2+ rises, 
producing contraction and vasoconstriction (Karpaimen, 1991).
hi a manner opposite that o f sodium, potassium is suggested to have a protective 
influence on BP through an activation o f the Na+-K+ pump (Karpaimen, 1991 ; Preuss, 
1993). In view o f this, comparisons were made between BP measures and both the 
absolute and relative (to Na+) measures o f K+. While no significant associations were 
determined by the kappa statistic, although a protective influence of K+ is suggested with 
trends showing RR and OR values less than one. Similarly, absolute and relative (to 
Mg2+) Ca2+ measures were compared with BP. These were performed as it may be the 
relative ratio o f Ca2+/Mg2+ that is o f  importance with both cations competing for 
extracellular and intracellular binding sites (Karpannen, 1991; Altura & Altura, 1996). 
However, no significant associations were demonstrated.
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5.2 BLOOD PRESSURE. BMI. AND PHYSICAL ACTIVITY
Comparisons o f BMI and BP across the total group and by sex were consistent with
reports that BMI is the strongest correlate o f  BP (Preuss, 1993). RR values greater than 
one and a half times were determined to exist for all BP measures (DBP, SBP, MAP) 
with BMI for the total group. These findings were maintained in DBP-BMI comparisons 
in males, and both SBP-BMI and MAP-BMI comparisons in females. Significant kappa 
statistics were found in all these cases and indicated that high and low BP measures are 
associated with high and low BMI measmes, respectively. Preuss (1993) proposes that 
the increased RR associated with a high BMI may be due to perturbations in sympathetic 
nervous activity and an elevated cardiac output. These findings are consistent with 
Kaplan (1986) who reported that people with a body weight 20% or more above ideal 
have a frequency o f hypertension about two times greater than do the non-obese.
Contrary to the findings o f Tomiak and Gentleman (1993) in the Canada Health 
Survey, no significant associations were found between PAS (physical activity scores) 
and BP. It was anticipated that a protective influence o f  PAS on BP would be 
demonstrated. This result was not surprising as only 10 subjects scored below the 
median score for PAS. That is to say that almost all subjects were “highly active” and the 
few below the median score still achieved an “adequate” PAS. Either the sample 
contained individuals truly at an adequate level o f  physical activity or the CPAFLA 
questionnaire was not sensitive enough to separate individuals across a physical activity 
continuum for a BP association to be seen.
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5.3 CONCLUSIONS AND SUGGESTIONS FOR FURTHER RESEARCH
This study concluded that a protective relationship between dietary magnesium and 
BP is not demonstrated in normotensive individuals. As well, there is no relationship 
between iMg and BP within the normal variation of iMg levels. It may be that there is a 
threshold effect of iMg on BP such that the contractility of vascular smooth muscle is 
influenced only at low iMg values. Studies that have shown a hypotensive influence of 
Mg supplementation may be due to the correction of an underlying magnesium 
deficiency within hypertensive subjects. In otherwise healthy individuals, it is unlikely 
that hypomagnesemia will result with the ingestion of a normal diet. As such, it further 
seems unlikely that supplementation in healthy individuals will prevent the development 
o f hypertension.
Further research is needed in the area of the etiology o f hypomagnesemia, as well as 
the establishment of normal and abnormal iMg levels. A review of clinical studies should 
be performed in order to determine at what point a threshold influence o f LMg on BP is 
observed. As well, it would be valuable to investigate whether or not magnesium 
depletion relates to the onset o f hypertension. That is to say that hypertension may not 
initially be accompanied by magnesium deficiency but rather, magnesium deficiency 
develops transiently through some disease process involved in hypertension. It may be 
that magnesium supplementation is only a valuable adjunctive therapy for hypertension 
in such magnesium-depleted individuals.
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Appendix A
CPAFLA PHYSICAL ACTIVITY QUESTIONNAIRE (PAQ)
Please answer the following questions:
1. Over a typical seven day period, how many time do you engage in physical 
activity that is sufficiently prolonged and intense to cause sweating and a rapid 
heart beat? (circle).
At least three times Normally once or twice Rarely or never
2. When you engage in physical activity, do you have the impression that you: 
(circle)
Make an intense effort Make a moderate effort Make a light effort
3. Generally, would you say that your current level o f physical fitness is: (circle) 
Very good Good Average Poor Very Poor
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Appendix B
SCORING FOR THE CPAFLA PAQ
Scoring Template
Item Male Female M ale Female Male Female
Question #1 Rarely or Never Once or twice A t least three
Frequency 0 0 2 1 3 3 5
Question #2 Light Moderate Intense
Intensity 0 0 1 2 3 3
Question #5 
Perceived
Very Poor Average Good or Very 
good
Fitness 0 0 3 1 5 3
Healthy Physical Activity Participation — 
Determination o f  Health Benefit Zones
Health Benefit Z ône Total Score Rank Score
Excellent 9-11 5
Very Good 6-8 4
Good 4-5 3
Fair 1-3 2
Needs Improvement 0 1
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Appendix C
M CNEM AR Cm -SQ Ü A RE TEST O F SYM M ETRY FO R  
PAIRED RESPONSE DATA
Computation of McNemar*s test
McNemar’s test assumes that the response data are binary. In this study, all variables 
were dichotomously scored relative to their median score such that the binary responses 
had one the following outcomes:
High factor “a” score & High factor “b” score 
High factor “a” score & Low factor “b” score 
Low factor “a” score & High factor “b” score 
Low factor “a” score & Low factor “b” score
(note: “high” scores are those at or above the median score for that variable; “low scores 
are those below the median)









The McNemar equivalence estimate focuses on “discordant pairs”, also referred to as 
“off-diagonal” elements (ie. the paired data in cells “B” and “C”). The null hypothesis 
(Ho: pB = pC) implies that the proportion of individuals who scored low on factor B and 
high on factor A will equal the proportion o f individuals who scored low on factor A and 
high on factor B (Suchower and Copenhaver, 1996). The McNemar test is computed 
using a z formula as shown below:
z = B - C
\ l  B  +
The null hypothesis is rejected when a significant z score results (z > 1.96).
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Appendix C continued
Sam ple Calculation: Comparison o f  DBP- iNa Responses
Low iNa High iNa
Low DBP 50 49
High DBP 30 72
z = 4 9 -3 0
49 + 30
z = 2.14
Therefore, the null hypothesis is rejected.
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Appendix D
AGREEMENT IN  PAIRED RESPONSE DATA USING THE KAPPA STATISTIC
Computation o f  the kappa statistic
The kappa statistic is used to determine the agreement in pairs o f responses. Complete 
agreement between the factors is assumed when kappa equals 1. Conversely, a kappa 
statistic o f 0 indicates that the agreement is coincidental and not different than that which 
would be expected by chance (Suchower and Copenhaver, 1996).
The kappa statistic focuses on the diagonal elements in cells “A” and “D”, as 
illustrated in the 2X2 table in Appendix C. The formula for the calculation o f kappa uses 
the proportion of events in the 2X2 table according to the following:
^  =  Po - Pc
1- Pc
Note: Po refers to the observed proportion and pe refers to the expected proportion where:
Po = the sum of the proportion of the total respondents represented by cells A and D 
Pe = the sum of the product for each matched row with column proportion
The null hypothesis (Ho: AT = 0) is tested by z according to:
z =  K
S C o (X )
(Note: seo (X) refers to the standard error for kappa)
Sample Calculation: Comparison ofDBP-iNa Responses:
Using the example in Appendix C and the above formulae, the following is obtained:
kappa = 0.2117 
z = 3.068
Therefore, the null hypothesis is rejected and a significant 21% agreement between DBP- 
iNa paired responses is demonstrated.
52
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix E  
RELATIVE RISK  
Computation o f  Relative Risk
Relative Risk (RR) refers to the ratio o f  the risk o f an outcome in individuals with a 
factor o f  interest to the risk o f  an outcome in individuals without the factor o f  interest. 
For example, in the 2X2 table shown below, a  high BP is the outcome and a high ionic 
sodium concentration is the factor o f  in terest. In this model, a high BP is also considered 
to be a “case” and high ionic sodium concentration is considered to constitute 
“exposure”. The RR risk is calculated as the ratio o f the incidence o f high BP among the 
ionic sodium group, to the incidence o f high BP in the low ionic sodium group.
Cases: Disease Present 
High Blood Pressure











RR = incidence o f the disease in the exposed group 
incidence o f the disease in the non-exposed group
RR =
A /(A +B )
C /  (C+D)
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